| |
|
|
|
Avadel Pharmaceuticals Plc  
|
|
6.81 0.06 (0.01%) |
01-25 16:00 |
|
Open: |
6.86 |
Pre close: |
6.75 |
Target:
|
8.49 
|
|
High: |
7.03 |
Low: |
6.62 |
Resistance:
|
7.27
7.87
|
|
Volume: |
471,616 |
Market Cap: |
397M |
Support:
|
6.29
5.23
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.76
 |
MACD |
MACD(12,26):
|
-0.02 |
|
MA(20): |
6.71 |
Signal(12,26,9): |
-0.03 |
|
MA(100): |
6.22 |
Stochastic Oscillator |
%K(14,3):
|
60.10 |
|
MA(250): |
7.48 |
%D(3): |
60.83 |
|
Average Volume(K) |
3-Month: |
46188
|
52-Week |
High:
|
13.49 |
|
10-Days: |
28938 |
Low: |
4.00 |
|
RSI |
RSI(14):
|
51.28 |
Change(%): |
4.0 |
|
Financials, Statistics and Valuation |
|
EPS |
0.320 |
Return on Equity (ttm) |
21.6 |
Shares Out. (M) |
58.27 |
|
EPS Est. Current Year |
1.160 |
Return on Assets (ttm) |
-7.6 |
Shares Float (M) |
41.76 |
|
EPS Est. Next Year |
0.250 |
PEG Ratio |
0.00 |
% Held by Insiders |
5.89 |
|
EPS Est. Next Quarter |
-0.100 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
56.94 |
|
Forward EPS |
-0.890 |
Gross Profit (p.s.) |
0.808 |
Shares Short (K) |
4110 |
|
Book Value (p.s.) |
2.940 |
EBITDA (p.s.) |
-0.469 |
P/E |
21.28 |
|
Sales Per Share |
0.572 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.32 |
|
Profit Margin |
46.71 |
Operating Cash Flow
(M) |
-37.86 |
P/S |
11.90 |
|
Operating Margin |
-88.35 |
Levered Free Cash Flow
(M) |
-56.07 |
P/CF |
-10.48 |
|
|
|
|
|
|
